The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

688 indexed citations

Abstract

loading...

About

This paper, published in 2011, received 688 indexed citations. Written by Anna Merlos‐Suárez, Francisco M. Barriga, Peter Jung, Mar Iglesias, María Virtudes Céspedes, David Rossell, Marta Sevillano, Xavier Hernando‐Momblona, Victoria da Silva-Diz and Purificacı́on Muñoz covering the research area of Oncology, Genetics and Psychiatry and Mental health. It is primarily cited by scholars working on Oncology (447 citations), Molecular Biology (407 citations) and Cancer Research (185 citations). Published in Cell stem cell.

Countries where authors are citing The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

Specialization
Citations

This map shows the geographic impact of The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse more than expected).

Fields of papers citing The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1016/j.stem.2011.02.020.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infections Breakdown of academic impact, for the paper The benefits of coding over routing in a randomized setting Breakdown of academic impact, for the paper Habit Persistence, Asset Returns, and the Business Cycle Breakdown of academic impact, for the paper d -Amino Acids Trigger Biofilm Disassembly Breakdown of academic impact, for the paper Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps Breakdown of academic impact, for the paper Rare Variants of IFIH1 , a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes Breakdown of academic impact, for the paper Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis Breakdown of academic impact, for the paper Regulation of the Arabidopsis Transcriptome by Oxidative Stress Breakdown of academic impact, for the paper Disease-induced assemblage of a plant-beneficial bacterial consortium Breakdown of academic impact, for the paper Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Rankless by CCL
2026